We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Avient
AVNT
$3.36B
| $34.1M | 0.15% |
912,600
-62,800
| -6% | -$2.38M |
|
|
AET
202
DELISTED
Aetna Inc
AET
| $34M | 0.15% |
319,586
+97,623
| +44% | +$9.56M |
|
203
Lockheed Martin
LMT
$131B
| $34M | 0.15% |
167,535
-2,093
| -1% | -$413K |
|
|
204
Vertex Pharmaceuticals
VRTX
$120B
| $33.9M | 0.15% |
287,069
+280,428
| +4,223% | +$33.6M |
|
205
Old Dominion Freight Line
ODFL
$48B
| $33.6M | 0.15% |
1,305,000
+300,000
| +30% | +$7.59M |
|
206
Hain Celestial
HAIN
$49.1M
| $33.3M | 0.15% |
520,000
| – | – |
|
|
ATVI
207
DELISTED
Activision Blizzard
ATVI
| $33M | 0.15% |
1,451,493
+161,422
| +13% | +$3.53M |
|
208
Prologis
PLD
$135B
| $32.9M | 0.14% |
754,200
-431,834
| -36% | -$18.9M |
|
|
SBNY
209
DELISTED
Signature Bank
SBNY
| $32.7M | 0.14% |
252,500
| – | – |
|
210
Thermo Fisher Scientific
TMO
$213B
| $32.7M | 0.14% |
243,441
-7,546
| -3% | -$973K |
|
211
Crown Holdings
CCK
$12.5B
| $32.7M | 0.14% |
604,523
+9,523
| +2% | +$473K |
|
212
Fomento Económico Mexicano
FMX
$43.3B
| $32.6M | 0.14% |
349,000
| – | – |
|
213
Goodyear
GT
$2.02B
| $31.8M | 0.14% |
1,175,000
-525,000
| -31% | -$13.7M |
|
214
Albemarle
ALB
$13.8B
| $31.7M | 0.14% |
600,516
-3,173
| -0.5% | -$173K |
|
|
KRFT
215
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $31.6M | 0.14% |
363,163
-8,253
| -2% | -$545K |
|
216
Sherwin-Williams
SHW
$76.6B
| $31.4M | 0.14% |
331,053
+6,996
| +2% | +$652K |
|
217
Boston Properties
BXP
$10.8B
| $31.3M | 0.14% |
223,026
-16,211
| -7% | -$2.26M |
|
|
CIT
218
DELISTED
CIT Group Inc.
CIT
| $31M | 0.14% |
687,500
| – | – |
|
219
Netflix
NFLX
$287B
| $30.9M | 0.14% |
5,197,710
+3,091,200
| +147% | +$18.8M |
|
|
220
Lazard
LAZ
$4.24B
| $30.5M | 0.13% |
+580,430
| New | +$28.6M |
|
221
Caterpillar
CAT
$412B
| $30.4M | 0.13% |
380,382
-14,034
| -4% | -$1.17M |
|
222
Prudential Financial
PRU
$40.9B
| $30.4M | 0.13% |
378,890
-74,153
| -16% | -$6.01M |
|
223
Regeneron Pharmaceuticals
REGN
$68.3B
| $30.3M | 0.13% |
67,193
-1,211
| -2% | -$513K |
|
224
ATI
ATI
$27.3B
| $30M | 0.13% |
1,000,000
| – | – |
|
225
Wabtec
WAB
$50.3B
| $29.8M | 0.13% |
313,164
+648
| +0.2% | +$58.4K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.